. Author manuscript; available in PMC: 2015 Apr 1.

Published in final edited form as: Breast Cancer Res Treat. 2014 Mar 2;144(3):591–597. doi: 10.1007/s10549-014-2891-0

Table 2. Univariate predictors of 12-month CRA (n = 124).

Characteristic	No CRA (n = 22)	CRA (n = 102)	p value
AMH (median)	1.3 ng/mL	0.08 ng/mL	<0.0001
Age (median)	36.5 years	46 years	<0.0001
Race			0.31
White	17	89
Other	5	13
Treatment arm			0.03
No bevacizumab	10	20
Bevacizumab	12	82
Tamoxifen use			1.00
No	11	49
Yes	11	53

CRA chemotherapy-related amenorrhea, AMH anti-mullerian hormone